Asthma Disease length | Follow-up visit Quantity
Item
1. subjects with documented clinical history of asthma for a period of at least 6 months prior to study entry (and a minimum of one clinic follow-up visit since initial diagnosis)
boolean
C0004096 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0589121 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Informed Consent | Comprehension Informed Consent
Item
2. willing to provide written informed consent and in the judgment of the investigator, individuals who are able to understand the informed consent process.
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C0021430 (UMLS CUI [2,2])
Airway Reversibility Percentage | FEV1 | Status pre- Adrenergic beta-2 Receptor Agonist Inhalation | Status post Adrenergic beta-2 Receptor Agonist Inhalation | Albuterol
Item
3. subjects with documented clinical history (in preceding 12 months) of airway reversibility of at least 12% based on forced expiratory volume (fev1), measured pre and post inhalation of a β-2 agonist (2 puffs of albuterol using a measured dose inhaler with spacer) or
boolean
C0458827 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0849974 (UMLS CUI [2])
C0332152 (UMLS CUI [3,1])
C2936789 (UMLS CUI [3,2])
C0205535 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C2936789 (UMLS CUI [4,2])
C0205535 (UMLS CUI [4,3])
C0001927 (UMLS CUI [5])
Airway Reversibility Percentage | Recruitment Testing | Symptoms Asthmatic
Item
4. individuals demonstrating airway 12% reversibility during recruitment testing and asthmatic symptoms, but with no prior history of asthma and not on an asthma treatment plan, can be recruited as affected individuals if in the opinion of the investigator the individuals are truly asthmatic and have no confounding factors that could explain the reversibility and symptoms.
boolean
C0458827 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0242800 (UMLS CUI [2,1])
C0039593 (UMLS CUI [2,2])
C1457887 (UMLS CUI [3,1])
C0004096 (UMLS CUI [3,2])
History of asthma | Symptoms Absent | Asthma well controlled | Pharmaceutical Preparations Asthma
Item
7. individuals with strong history of asthma but with waning, or no current symptoms may be included in the study if their asthma was well controlled using an asthma medication. principal investigator must verify or know the clinical history of an individual before accepting him as an asthmatic individual.
boolean
C0455544 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C4296063 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
History of asthma | Absence Pharmaceutical Preparations Asthma | Family history of asthma
Item
8. individuals with positive history of asthma but no asthma medication usage and with family history of asthma should be considered for inclusion as cases in the study only if other family members are being recruited.
boolean
C0455544 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0004096 (UMLS CUI [2,3])
C1261327 (UMLS CUI [3])
Ability Perform Spirometry | Ability Perform FEV1
Item
9. able to perform spirometry/fev1 correctly (only for those above 7years).
boolean
C0085732 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
C0037981 (UMLS CUI [1,3])
C0085732 (UMLS CUI [2,1])
C0884358 (UMLS CUI [2,2])
C0849974 (UMLS CUI [2,3])
Age
Item
1. age < 3 years
boolean
C0001779 (UMLS CUI [1])
Tobacco use | Smoking cigarettes: ____ pack-years history
Item
2. smoking for 20 years, 1 pack/day or more.
boolean
C0543414 (UMLS CUI [1])
C2230126 (UMLS CUI [2])
Congestive heart failure
Item
3. congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
Chronic Obstructive Airway Disease
Item
4. copd.
boolean
C0024117 (UMLS CUI [1])
Chronic lung disease | Exception Asthma | Exception Chronic Obstructive Airway Disease
Item
5. chronic lung disease other than asthma and copd.
boolean
C0746102 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0024117 (UMLS CUI [3,2])
Bronchiectasis
Item
6. bronchiectasis.
boolean
C0006267 (UMLS CUI [1])